ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,636.00
-15.00 (-0.91%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -15.00 -0.91% 1,636.00 1,638.00 1,639.00 1,661.50 1,635.50 1,656.50 4,329,161 16:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.69 67.46B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,651p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.46 billion. Gsk has a price to earnings ratio (PE ratio) of 13.69.

Gsk Share Discussion Threads

Showing 27351 to 27371 of 33100 messages
Chat Pages: Latest  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  1085  Older
DateSubjectAuthorDiscuss
02/7/2021
08:57
Elliot has done much more for the price than the admiral's daughter has.Mind you, she'll be in line for another top job at brains or similar, she must have thousands of management consultants planning the split. Any numbers on the cost of consultants to GSK the last couple of years?I don't think the pseudo non science of face cream management is much use for managing a scientific pharma company. Looks like GSK wokery appointment to me.
pierre oreilly
02/7/2021
08:55
Unilever is the biggest company in FTSE100
so I'm assuming the consumer side of Glaxo is by
miles the biggest - probably the bulk of
the £73b (it has some amazing brands).

Once the consumer side is floated off - £50-60b?
Will we start to see some value for drug side?

Currently drug side valued at £10-20b but aztraZenica
valued at £150b (TEN TIMES BIGGER)

Could drug side of Glaxo be a ten bagger - given time?

netcurtains
02/7/2021
08:48
Rupert Murdoch and Elliot have had dealings before, so I guess The Times focus on the CEO may well have been directed from the top.
alex1621
02/7/2021
08:28
Whatsup

Agreed. Pity they cannot bloody disclosure the size of Elliots stake.
This omission, in my view, means GSK management feel confident in given Elliott the "bird"

geckotheglorious
02/7/2021
08:24
The Times have 3 pages on GSK today.

I'm sure they're getting a bung

whatsup32
02/7/2021
08:05
By the time the split comes round shingrix will be flying again and Elliott will be cashing in anyway. Keep riding the coattails
daneswooddynamo
02/7/2021
07:59
Elliot adopting role of a stalking horse. Getting the conversation going, can't see how Emma is going to survive them, she has right strategy but does not seem to impress, board will do what Elliot suggest and get heavyweight pharma person in
ayl30
02/7/2021
07:57
Are we talking about a take-over bid here for 50% of business?
netcurtains
02/7/2021
07:19
Well its put up or shut up time. If Elliott has anything under 5% it will be like taking a water pistol to a gun fight.
whatsup32
02/7/2021
06:57
Of course not over 3% they would have to make a rns announcement.All their moaning, they can't do sweet FA. Ramping up the price through the press, then they will sell out for a nice profit. 13F filings will tell us.
montyhedge
02/7/2021
00:37
Wall St raider declares war on GSK boss: Activist investor Elliott Advisors claims demands Emma Walmsley reapply for her own job
philanderer
02/7/2021
00:35
'Elliott pushes for private equity sale of GSK's £40bn consumer arm'


The move would derail boss Emma Walmsley's plan to carve out the business, and puts her position under even greater pressure

philanderer
02/7/2021
00:34
'GSK’s Emma Walmsley is almost defenceless in her fight against Wall Street raider'
philanderer
01/7/2021
22:17
She's got to go, plain and simple. Clinging on like a 30 year old limpet to the keel of a Brixton trawler. spud
spud
01/7/2021
20:45
The Emperor Elliott has no trousers.
netcurtains
01/7/2021
20:42
Abdulla
They havent notified their stake size yet so must be under 3% (as they've had enough sodding time now to make necessary disclosure)

beyond farce now.
Notification of any stake over 2%(including CFD/other synthetic exposure) should be by the end of the same business day...

It isnt sodding difficult. It's laziness at best.

geckotheglorious
01/7/2021
20:18
They say they have a significant stake,must be over 3%
abdullla
01/7/2021
20:11
Will let you know, form 13F does not lie, see how much Elliott Management really have in the game. We know no declarable stake.
montyhedge
01/7/2021
20:02
GlaxoSmithKline (GSK) Investor Presentation - Slideshow
geckotheglorious
01/7/2021
19:41
SE on Thrusday said it will acquire a research and development facility in Verona, Italy from pharmaceutical firm GlaxoSmithKline PLC. Financials not disclosed
abdullla
01/7/2021
19:33
No not yet. Some say he's not got a declarable stake. Others beg to differ!spud
spud
Chat Pages: Latest  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  1085  Older

Your Recent History

Delayed Upgrade Clock